Office for Human Research Protections (OHRP)
Food and Drug Administration (FDA)
- FDA Information and Regulations
- Good Clinical Practice in FDA-Regulated Clinical Trials
- Protection of Human Subjects 21 CFR 50
- Institutional Review Boards 21 CFR 56
- Investigational New Drug Application 21 CFR 312
- Investigational Device Exemptions 21 CFR 812
Veterans Affairs (VA) Administration
- Working with the San Francisco VAMC
- VHA Handbook 1058.01
- 38 CFR Part 16 - Protection of Human Subjects
Department of Defense (DoD)
Department of Energy (DOE)
Department of Education
Department of Justice
Environmental Protection Agency
HIPAA
International
National Institutes of Health
- NIH Protection of Human Research Subjects Online Training Module and Frequently Asked Questions
- ClinicalTrials.gov Registry
- Certificate of Confidentiality Kiosk
California State Statutes
- Protection of Human Subjects in Medical Experimentation Act (§ 24170-24179.5)
- Use of State Death Data Records § 102231 - 102232
- Experimental Use of Drugs and Consent for Minors Participation (§ 111515-111545)
- Use of Opioid, Stimulant and Hallucinogenic Drugs in Research (§ 11480-11481)
- California Information Practices Act (Civil Code § 1798.24) (SB 13)
- California Medical Information Act (CMIA) (Civil Code § 56.10)
Ethical Principles and Codes
- National Bioethics Advisory Commission
- Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research
- Nuremberg Code
- World Medical Association Declaration of Helsinki
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)